Brigitte Thomas, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1949 Ne Lotus Dr, Bend, OR 97701 Phone: 541-729-6837 |
Laura Shea Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 131 Nw Hawthorne Ave Ste 103, Bend, OR 97703 Phone: 541-604-8255 |
Savannah Couch, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 900 Ne 27th St, Bend, OR 97701 Phone: 541-382-0479 |
Allison Young, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 444 Ne Norton Ave Ste 102, Bend, OR 97701 Phone: 541-668-3757 |
Erica Hoffman, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1406 Nw Juniper St, Bend, OR 97703 Phone: 541-389-5437 |
Melissa Diane Mcpherson, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3790 Ne Purcell Blvd, Bend, OR 97701 Phone: 541-355-4329 |
Neuro Slp Services Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1372 Ne Whisper Ridge Dr Apt 3, Bend, OR 97701 Phone: 402-515-0538 |
Elizabeth Moore Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 20310 Empire Ave Ste A103, Bend, OR 97703 Phone: 541-604-8255 |
Claire Powell, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 155 Se Windance Ct, Bend, OR 97702 Phone: 541-280-8907 |
Ms. Alison Goin, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 954 Ne Lena Pl, Bend, OR 97701 Phone: 541-280-8177 |
Bend Speech-language Clinic Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 760 Nw Harriman St Ste 200, Bend, OR 97703 Phone: 541-420-5934 |
Anna Wilhoit, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2434 Nw 2nd St, Bend, OR 97701 Phone: 541-233-3008 |
Juniper Speech And Language Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2986 Ne Red Oak Dr, Bend, OR 97701 Phone: 303-242-7716 |
Stephanie M Canfield Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 520 Nw Wall St, Bend, OR 97703 Phone: 541-355-2522 |
Christine Chavez, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 131 Nw Hawthorne Ave Ste 101, Bend, OR 97703 Phone: 541-604-8255 |
Mary Burns, MS, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 131 Nw Hawthorne Ave Ste 103, Bend, OR 97703 Phone: 541-604-8255 |
Myohub Consulting Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2863 Nw Crossing Dr Ste 218, Bend, OR 97703 Phone: 541-728-3306 Fax: 541-550-2912 |
Stephanie Jill Marz, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1086 Nw Stannium Rd, Bend, OR 97701 Phone: 541-382-2585 Fax: 541-382-2585 |
Mrs. Alicia M Fox Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 700b Nw 11 Street, Oregon Scottish Rite Clinic, Bend, OR 97701 Phone: 541-389-8201 Fax: 541-389-8201 |
Catherine D. Collins, MA CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 408 Ne Hawthorne Ave, Bend, OR 97701 Phone: 503-657-8903 |
News Archive
Scott Gottlieb, the commissioner of the United States Food and Drug Administration (FDA) has announced that he would resign from office at the end of this month.
The impact of eating disorders in the United States was nearly $400 billion in 2018-19 when considering both economic costs and reduced wellbeing, according to a study published in the International Journal of Eating Disorders.
IRIDEX Corporation, a leading global provider of innovative laser systems, delivery devices and consumables in ophthalmology, today announced that it has received its CE Mark to commercialize across Europe its first laser system in its class designed solely for use in treating glaucoma and its symptoms.
Rich Pharmaceuticals, Inc. is pleased to announce that the Company has received approval from the U.S. Food and Drug Administration to commence its Phase 1/2 clinical for the treatment of Acute Myelocytic Leukemia (AML) and Myelodysplastic Syndrome (MDS) patients.
› Verified 9 days ago